Source: UK House of Commons
Date: March 5, 2021
URL:
https://questions-statements.parliament.uk/written-questions/detail/2021-02-22/156362
Ref:
http://www.me-net.combidom.com/meweb/web1.4.htm#westminster
[Written Answers]
Coronavirus: Vaccination
------------------------
Paul Blomfield
To ask the Secretary of State for Health and Social Care, what
assessment he has made of the potential merits of prioritising people
with ME and chronic fatigue syndrome for covid-19 vaccination.
Nadhim Zahawi
The Joint Committee on Vaccination and Immunisation (JCVI) has not
identified any robust data to indicate that, as a group, persons with
myalgic encephalomyelitis/chronic fatigue syndrome are at higher risk of
mortality from COVID-19 and therefore are not included as a group for
prioritisation for vaccination in the vaccine programme.
Prioritisation for phase two has not yet been decided, but interim
advice has been published by the JVCI recommending an age-based approach
which the Government has accepted in principle. Phase two of the
COVID-19 vaccine programme will cover all adults under 50 not already
included in Phase one.